BACKGROUND
Macrophage activation syndrome (MAS) is a rare but potentially life-threatening complication of juvenile dermatomyositis (JDM). Data on its clinical presentation, diagnosis, treatment, and outcomes remain limited.
OBJECTIVE
To systematically review the literature on MAS occurring in patients with JDM.
ME...
Martina Rossano, Francesco Baldo, Pasquale Vaienna et al.· Current Opinion in Immunolog...· 0 citations
Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) in childhood is a rare but severe condition associated with significant morbidity and treatment-related toxicity. Current therapies mainly rely on high-dose glucocorticoids and conventional immunosuppressants, which may cause substantial long-term a...
Provini Chiara, Minoia Francesca, A. Mastrangelo et al.· Current Opinion in Immunolog...· 0 citations
The progressive elucidation of juvenile idiopathic arthritis (JIA) pathogenesis has led to growing interest in biomarkers to support diagnosis, subset classification, detection of subclinical inflammation, and/or prediction of disease course and therapeutic response (theragnostic biomarkers). JIA management in clinical...
A. Marino, Marco Pandolfi, M. G. Lommano et al.· Current Opinion in Immunolog...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.